DEERFIELD, Ill. (PRWEB) November 22, 2022
MOLLI Surgical’s wire-free and radiation-free breast cancer localization technology has been named to Fast Company’s second annual Next Big Things in Tech list. The award honors technology breakthroughs that promise to shape the future of their industries — from agriculture and environment to productivity and artificial intelligence. MOLLI Surgical has been recognized in the health category for its cutting-edge advancements in simplifying precision surgery to deliver an improved patient experience.
Marking the lesion for those needing breast cancer surgery has traditionally been a difficult experience for the patient — typically using a wire on the same day of surgery. MOLLI® is the smallest localization device on the market that precisely and reliably marks where the lesion is for the surgeon to remove it. The device is easy to use, reliable, and extremely precise, delivering an improved patient experience and better cosmetic results.
“Technology breakthroughs and cutting-edge advancements promise to be the solution to some of the world’s most pressing issues. Fast Company is excited to highlight some of the organizations, of all sizes and industry backgrounds, whose technology advancements today will lead to a better tomorrow,” says Brendan Vaughan, editor-in-chief of Fast Company.
MOLLI provides immense benefits to both patients and caregivers. The MOLLI Marker® — about the size of a sesame seed — can be detected using the MOLLI Wand® and its position is displayed like GPS visually with the MOLLI Tablet®. Because it’s the smallest localization device, the MOLLI Marker can deliver greater precision for marking and removing lesions, which means more surgical options for patients.
“What an incredible honor,” said Ananth Ravi, Ph.D., President, and CEO of MOLLI Surgical Inc. “Years ago, we listened to one patient who shared her story on the traditional wire localization method — specifically, the anxiety, pain, and discomfort she experienced while waiting for surgery. Listening to her inspired both the device and the company. Since then, we have been laser-focused on helping hospitals achieve even greater efficiencies and deliver a better overall patient experience.”
MOLLI Surgical is dedicated to creating devices that dramatically reduce the burden of treatment on patients, provide confidence to care teams and improve the efficiencies of health systems. To learn more, please visit mollisurgical.com.
Click here to see the final Next Big Things in Tech list, which will be included in the Winter 2022/2023 issue of Fast Company hitting newsstands on December 6.
About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Brendan Vaughan. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.
About MOLLI Surgical
MOLLI Surgical started in the operating room, where surgeons were using dated tools to treat cancer patients — and we knew we could do better. Our surgical wand is precise, reliable, easy to use, and built with the realities of the operating room in mind. More importantly, it is built with patients in mind. Our technology replaces procedures to mark lesions with one that is more precise, efficient, and cost-effective. MOLLI Surgical is proud to build the advanced equipment that patients prefer to have and that physicians prefer to use. Follow us on Facebook, LinkedIn, Twitter, and YouTube.